The Claim
Inhibition of cyclooxygenase-2 reduces food intake in KK-Ay mice, indicating that prostaglandin synthesis contributes to hyperphagia in this genetic obesity model in conjunction with endocannabinoid signaling.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Blocking the enzyme cyclooxygenase-2 decreases eating behavior in KK-Ay mice, suggesting that prostaglandins, along with endocannabinoids, play a role in driving excessive food intake in this genetically obese mouse strain.
See the scientific wording
Cyclooxygenase-2 inhibition reduces food intake in KK-Ay mice, suggesting that prostaglandin synthesis contributes to hyperphagia in this genetic obesity model alongside endocannabinoid signaling.
In these obese mice, a chemical called COX-2 makes more prostaglandins, which act on the brain’s hunger center and make the mice eat more. This happens at the same time as another system involving a brain chemical called 2-AG that also turns up the hunger signal. Blocking COX-2 reduces prostaglandins and makes the mice eat less.
What the research says
1 studyThe study found that giving mice a drug that blocks a specific body chemical (COX-2) made them eat less, and that same chemical was higher in obese mice. This suggests that this chemical helps drive overeating in these mice, just like the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.